Varian responds to Covid-19 with remote cancer patient monitoring
June 2, 2020
In response to the healthcare delivery changes brought on by Covid-19, California-based Varian has added capabilities to its Noona software application, a tool designed to engage cancer patients in their care for continuous reporting and symptom monitoring.
Noona supports cancer care teams as they face short- and long-term healthcare changes created by the pandemic by providing in-app features such as patient screening, real-time symptom reporting, secure care team messaging, telephone triage workflow automation and patient access to medical records. In addition, Varian has designed an approach to implement the app quickly and remotely to put it in the hands of cancer patients and care teams faster, without increasing the risk of Covid-19 exposure.
"In light of Covid-19 and the difficulties it poses to the current state of cancer care delivery, cancer patients are more vulnerable than ever," said Jeff Patton, executive chairman of Tennessee Oncology, one of the USA's largest community-based cancer care groups. "Now, more than ever, we need to remotely communicate with and manage our patients to protect them and our team who cares for them. Noona is invaluable for facing the results of the pandemic, and we are confident it will serve as a strong foundation in the new care landscape for clinicians and patients well into the future."
Noona has made a positive impact on care offered by Tennessee Oncology, with nearly 600 care team members using Noona; around 10,000 patients accessing the Noona patient app to report symptoms and communicate with clinicians; and about 31,000 patients being managed through the telephone triage workflow automation. Tennessee Oncology is experiencing even more demand for the Noona patient app with patient adoption steadily increasing by about 1000 new patients a month since the beginning of the pandemic.
"Telemedicine and digital communication are here to stay, so do it now and do it forever," Patton said. "Noona has helped us reduce the risk of exposure for patients and staff, while keeping our healthcare communities fully informed. Since the Covid-19 outbreak first hit, we've found our new abnormal and at the moment it's stable so we can function in a steady state."
The Varian product team developed and released a Covid-19-related symptom screening questionnaire. A series of questions specific to Covid-19 symptoms, as defined by the World Health Organisation and Centers for Disease Control & Prevention, guides the process and taps into severity grading options that, via a back-end algorithm, will alert the cancer clinic with a high alert status, allowing care teams to act quickly.
Due to the many requests for Noona from other cancer care organisations, the team also reengineered the implementation process to get other clinics up and running remotely and quickly. The rapid deployment process allows experts to configure and set up an entirely new cancer organisation and virtually train care team users through video conferencing tools and pre-built education materials in just a few weeks without being onsite.
"Noona has proven its ability to reduce emergency room visits and, with the altered state of healthcare brought on by Covid-19, the value that Noona offers has never been more needed," said Jani Ahonala, vice president at Varian. "When the current pandemic began, we reprioritised our team's daily activities to quickly help our customers and patients across the globe."
Varian has 10,000 employees across 70 locations.